Study of the benefits of collaboration between community and hospital pharmacists using electronic patient-reported outcomes (ePRO)

Study of the benefits of collaboration between community and hospital pharmacists using electronic patient-reported outcomes (ePRO) - PHARE-ONC 02 RT (Pharmacy and Hospital Alliance on Remote Engagement in Oncology 02 Rice Triangle Model) Study

Status

Active, not recruiting

Phases

Unknown

Study type

Observational

Source

JPRN

Registry ID

JPRN-UMIN000056035

Enrollment

100

Registered

2024-11-05

Start date

2024-11-05

Completion date

Unknown

Last updated

2026-06-29

For informational purposes only — not medical advice. Sourced from public registries and may not reflect the latest updates. Terms

Conditions

Malignancy

Interventions

None listed

Eligibility

Sex/Gender

All

Inclusion criteria

Inclusion criteria: Outpatients receiving pharmacotherapy for cancer Patients with a diagnosis of malignancy ECOG performance status 0-2 Age >=20 years at time of consent Prognosis expected to be at least 6 months as determined by physician Written informed consent Smartphone-enabled patients (or caregiver accessible)

Exclusion criteria

Exclusion criteria: Patients with obvious self-report difficulties due to their mental illness or cognitive impairment Concurrent participation in other PRO studies Patients with difficulty using a smartphone due to illness, adverse events, etc.

Design outcomes

Primary

Measure	Time frame
EuroQol 5 dimensions 5-level(EQ-5D-5L)	—

Secondary

Measure	Time frame
Person-centred primary care measure (PCM) at the end of the study Number of patients followed up Number of tracing reports Number of Gan Yakubutsu Ryoho Taisei Jujitsu Kasan (Cancer chemotherapy system enhancement surcharge) Number of Renkei Jujitsu Kasan (coordination system enhancement surcharge) Consultation and Relational Empathy (CARE) measure at end of study Pharmacist's prescription suggestion Proportion of prescription suggestions made by pharmacists that were accepted by physicians Proportion of ePRO responses and alerts Number of Tokutei Yakuzai Kanri Shido Kasan 2 (specific medication management and consultation surcharge) Number of telephone follow-ups End of study questionnaire for healthcare professionals and patients	—

Measure

Time frame

Person-centred primary care measure (PCM) at the end of the study Number of patients followed up Number of tracing reports Number of Gan Yakubutsu Ryoho Taisei Jujitsu Kasan (Cancer chemotherapy system enhancement surcharge) Number of Renkei Jujitsu Kasan (coordination system enhancement surcharge) Consultation and Relational Empathy (CARE) measure at end of study Pharmacist's prescription suggestion Proportion of prescription suggestions made by pharmacists that were accepted by physicians Proportion of ePRO responses and alerts Number of Tokutei Yakuzai Kanri Shido Kasan 2 (specific medication management and consultation surcharge) Number of telephone follow-ups End of study questionnaire for healthcare professionals and patients

—

Countries

Japan

Contacts

Public ContactShunsuke Kohyama

Saitama Medical University International Medical Center Department of Pharmacy

kohyama@saitama-med.ac.jp042-984-4190

Outcome results